Literature DB >> 8069391

Alveolar gradient of pentane in normal human breath.

M Phillips1, J Greenberg, M Sabas.   

Abstract

Previous studies have raised the question of whether pentane is a normal constituent of human breath, since its concentrations in inspired room air and expired breath are often similar. Using a highly sensitive assay for volatile organic compounds, we studied 37 normal subjects in order to determine the alveolar gradient of pentane in their breath (i.e. concentration in alveolar breath minus concentration in the inspired air). The chemical identity of pentane was confirmed by mass spectroscopy. The alveolar gradient of pentane was zero +/- 0.175 nmol/l in 54.1% of subjects, and distributed in an approximately bell-shaped curve. Determination of the alveolar gradient divided the normal subjects into three groups: the "passive equilibrators" who did not appear to excrete pentane in the breath (the majority), "metabolizers" who actively catabolized inhaled pentane, and "manufacturers" who excreted more pentane than they inhaled.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069391     DOI: 10.3109/10715769409145633

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  12 in total

1.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

Review 2.  Oxygen radicals, nitric oxide and human inflammatory joint disease.

Authors:  B Halliwell
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

3.  Selected ion flow tube mass spectrometry for targeted analysis of volatile organic compounds in human breath.

Authors:  Ilaria Belluomo; Piers R Boshier; Antonis Myridakis; Bhamini Vadhwana; Sheraz R Markar; Patrik Spanel; George B Hanna
Journal:  Nat Protoc       Date:  2021-06-04       Impact factor: 13.491

4.  Breath analysis in disease diagnosis: methodological considerations and applications.

Authors:  Célia Lourenço; Claire Turner
Journal:  Metabolites       Date:  2014-06-20

Review 5.  Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath.

Authors:  Alphus D Wilson
Journal:  Metabolites       Date:  2015-03-02

Review 6.  Understanding the Potential of WO₃ Based Sensors for Breath Analysis.

Authors:  Anna Staerz; Udo Weimar; Nicolae Barsan
Journal:  Sensors (Basel)       Date:  2016-10-29       Impact factor: 3.576

7.  Volatile organic compounds in ventilated critical care patients: a systematic evaluation of cofactors.

Authors:  Tobias Hüppe; Dominik Lorenz; Mario Wachowiak; Felix Maurer; Andreas Meiser; Heinrich Groesdonk; Tobias Fink; Daniel I Sessler; Sascha Kreuer
Journal:  BMC Pulm Med       Date:  2017-08-22       Impact factor: 3.317

8.  Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.

Authors:  Alessia Di Gilio; Annamaria Catino; Angela Lombardi; Jolanda Palmisani; Laura Facchini; Teresa Mongelli; Niccolò Varesano; Roberto Bellotti; Domenico Galetta; Gianluigi de Gennaro; Sabina Tangaro
Journal:  Cancers (Basel)       Date:  2020-05-16       Impact factor: 6.639

9.  Breath Analysis: Comparison among Methodological Approaches for Breath Sampling.

Authors:  Alessia Di Gilio; Jolanda Palmisani; Gianrocco Ventrella; Laura Facchini; Annamaria Catino; Niccolò Varesano; Pamela Pizzutilo; Domenico Galetta; Massimo Borelli; Pierluigi Barbieri; Sabina Licen; Gianluigi de Gennaro
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

10.  Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.

Authors:  Michael Phillips; Renee N Cataneo; Anirudh Chaturvedi; Peter D Kaplan; Mark Libardoni; Mayur Mundada; Urvish Patel; Xiang Zhang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.